All Articles

As Richelieu Hardware preps its Q2 results, all eyes are on whether its growth strategy can defy North America's economic headwinds. A critical test.

In an economy upended by AI and demographic shifts, leaders are ditching guesswork. A new report reveals the turn to data isn't a trend; it's survival.

Compass Datacenters' $12.6M facility donation aims to solve the tech skills gap, but it also reveals a complex blueprint for corporate-community partnership.

In a volatile market, insurtech firm Kin secured a stunning 25% cut in reinsurance costs. It's a powerful signal that AI-driven underwriting is rewriting the rules.

Webull Canada's new CIRO-approved crypto trading offers mainstream access, but a closer look reveals the unmitigated risks lurking beneath the regulatory sheen.

A massive $180M investment signals a new era where AI transforms rogue business messages on WhatsApp and Signal into governed, actionable data.

With celebrity chefs and travel gurus, Oceania Cruises is selling more than a vacation; it's selling curated connection. But does it deliver on the promise?

With an $85M insider-led round and a seasoned M&A expert as CEO, Flare Therapeutics sharpens its focus on a novel prostate cancer drug, FX-111.

As Mercy enters its third century, new mission leader Dan Ensell is tasked with embedding its Catholic values across a 50,000-person workforce.

With a near-total bond buyback, QXO has cleared a major financial hurdle in its massive TopBuild acquisition, paving the way for an industry-shaping merger.

FreightWise's new BI tool gives SMB shippers data analytics once reserved for corporations, promising direct cost savings and smarter decisions.

SEI expands its SEC-registered transfer agency, leveraging Envision's technology to tackle the operational complexities of semi-liquid alternative funds.

Cumulus Neuroscience's at-home EEG platform shows remarkable patient adherence, promising to accelerate drug trials and reshape the fight against dementia.

Vistagen's Phase 3 trial for its novel anxiety nasal spray fails its main goal, but a surprising signal in severe cases prompts a high-stakes pivot.

Following a $103M funding round, Kinaset Therapeutics adds proven dealmakers to its board, signaling a strategic push for its novel inhaled asthma therapy.

A landmark deal to convert a vacant office tower into 512 affordable homes is just the start. How a new city ordinance and a strategic partnership are creating a blueprint to solve LA's dual crises.

New data reveals how Genelux’s oncolytic virus reawakens chemotherapy's power, offering a potential lifeline in a notoriously difficult-to-treat cancer.

Orazio Buzza's win isn't just about food. It's about a tech-driven solution to the office culture crisis, powered by logistics, AI, and local restaurants.

Marga.ai's partnership with Eric Rozenberg promises an AI mentor with real judgment. But is digitizing expertise the future or a philosophical fallacy?

A new rule allows Roth contributions in SIMPLE IRAs, a huge shift for small firms. Ascensus is an early adopter, but what does this really mean for workers?